Synthesis and In vivo studies of the radiosensitizer 4-[82Br]bromomisonidazole
- 1 January 1983
- journal article
- research article
- Published by Elsevier in International Journal of Nuclear Medicine and Biology
- Vol. 10 (4), 205-210
- https://doi.org/10.1016/0047-0740(83)90080-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The Metabolism and Pharmacokinetics of the Hypoxic Cell Radiosensitizer and Cytotoxic Agent, Misonidazole, in C3H MiceRadiation Research, 1981
- A marker for hypoxic cells in tumours with potential clinical applicabilityBritish Journal of Cancer, 1981
- Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models —III. 2′-[82Br]-Bromo-2′-deoxyuridineInternational Journal of Nuclear Medicine and Biology, 1979
- The pharmacokinetics of misonidazole in the dogEuropean Journal of Cancer (1965), 1979
- Distribution of misonidazole in human tumours and normal tissuesBritish Journal of Cancer, 1979
- Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 miceBritish Journal of Cancer, 1979
- Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumoursBritish Journal of Cancer, 1979
- Clinical testing of the radiosensitizer Ro 07-0582: Experience with multiple dosesBritish Journal of Cancer, 1977
- The Histological Structure of Some Human Lung Cancers and the Possible Implications for RadiotherapyBritish Journal of Cancer, 1955